MINNETONKA, Minn. and MIAMI, Fla., Oct. 9, 2025 — Monteris Medical and Symphony Robotics have entered a strategic collaboration to develop an AI-driven micro-robotic platform that enhances laser interstitial thermal therapy (LITT) for treating complex brain tumors. The alliance aims to combine Monteris’ NeuroBlate® laser system with Symphony’s flexible, MRI-guided robotic arm, improving precision, safety, and accessibility in minimally invasive neurosurgery.
Science Significance
The partnership advances AI-integrated neurosurgical robotics, offering unprecedented control during laser ablation procedures. Symphony’s robotic arm can operate within the MRI bore, navigating curved trajectories to reach multiple or irregular brain lesions. This allows for real-time MRI-guided ablation of complex tumors such as glioblastoma and neurofibromatosis, setting a new benchmark for precision in brain surgery.
Regulatory Significance
The collaboration supports future FDA submissions for Symphony’s robotic system, which is currently in premarket development and not yet approved for clinical use. Monteris’ FDA-cleared NeuroBlate System, combined with Symphony’s platform, represents a pathway toward expanded regulatory indications for integrated robotic-assisted laser ablation systems. This aligns with global regulatory trends promoting AI-enabled medical devices under rigorous safety and performance frameworks.
Business Significance
Advertisement
For Monteris, this collaboration enhances its leadership in robotically controlled laser ablation by integrating next-generation micro-robotics and AI. For Symphony Robotics, the partnership accelerates product validation, market access, and commercialization through Monteris’ established neurosurgical network. The alliance underscores a broader trend in strategic MedTech collaborations bridging surgical robotics and imaging technologies.
Patients’ Significance
Patients with hard-to-reach brain tumors or epilepsy lesions may benefit from greater surgical precision and fewer complications. The micro-robotic platform allows for smaller incisions, faster recovery, and reduced hospitalization time compared to open craniotomies. This innovation also holds promise for improving survival and quality of life for patients with aggressive brain cancers like glioblastoma.
Policy Significance
This collaboration aligns with U.S. health policy priorities to expand access to minimally invasive, AI-enabled medical devices. The partnership supports innovation under emerging frameworks for AI transparency, safety, and real-time learning systems in healthcare, reinforcing the FDA’s commitment to advancing robotic-assisted surgical technologies.
The partnership between Monteris Medical and Symphony Robotics represents a leap forward in neurosurgical innovation. By merging AI, robotics, and MRI-guided precision, the collaboration could redefine the standard of care for laser ablation in the brain — providing a safer, smarter, and more effective solution for patients facing the most complex neurological disorders.
Source: Monteris Medical press release
